Charles River Laboratories International Beats Analyst Estimates on EPS

Seth Jayson, The Motley Fool
Updated

Charles River Laboratories International (NYS: CRL) reported earnings on Oct. 30. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 29 (Q3), Charles River Laboratories International met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue was unchanged and GAAP earnings per share grew significantly.


Margins increased across the board.

Revenue details
 Charles River Laboratories International chalked up revenue of $278.7 million. The 14 analysts polled by S&P Capital IQ expected to see a top line of $278.8 million on the same basis. GAAP reported sales were 0.4% higher than the prior-year quarter's $277.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.65. The 18 earnings estimates compiled by S&P Capital IQ predicted $0.62 per share. GAAP EPS of $0.46 for Q3 were 24% higher than the prior-year quarter's $0.37 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 33.5%, 10 basis points better than the prior-year quarter. Operating margin was 13.5%, 10 basis points better than the prior-year quarter. Net margin was 7.9%, 110 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $289.9 million.

Next year's average estimate for revenue is $1.14 billion.

The article Charles River Laboratories International Beats Analyst Estimates on EPS originally appeared on Fool.com.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement